Clinical Trial Update: Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effect of N-acetylcysteine on oxidative stress in COVID-19 patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Related Oxidative Stress

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ain Shams University | Conditions: Corona Virus Disease 19 (Covid19), Corona Virus Infection | Phase 3 | Status: COMPLETED